Abstract:SESSION TITLE: Chest Infections II SESSION TYPE: Case Report Poster PRESENTED ON: Sunday, April 17, 2016 at 11:45 AM - 12:45 PM INTRODUCTION: Cytomegalovirus (CMV) is a major β herpes virus and a significant human pathogen. CMV infection has been shown to lead to significant disease in immunocompromised hosts such as those with HIV infection or transplant recipients. It has increasingly come to be recognized that critically ill patients who are traditionally considered immunocompetent may also be at risk for CMV infection. CASE PRESENTATION: Two elderly patients were admitted to our Respiratory Intensive Care Unit for severe pneumonia and hypoxemic respiratory failure. After about 2 weeks’ treatment including invasive mechanical ventilation, broad-spectrum antibiotics and corticosteroids, their oxygenation improved with resolution of lung infiltrates on chest radiograph. On the course of recovery, their oxygenation deteriorated again and lung infiltrates extended without positive pathogenic findings of bacteria and fungi. Unexpectedly, their blood CMV DNA became positive and then they were treated with parenteral ganciclovir for more than 2 weeks. After that, their oxygenation and chest radiograph returned to normal. DISCUSSION: Invasive mechanical ventilation and use of corticosteroids could be the risk factors of immunocompetent subjects to develop CMV infection after severe pneumonia. The clinical characteristics include deterioration of oxygenation and extensive lung infiltrates without positive pathogenic findings of bacteria and fungi. Quantitive nucleic acid amplification tests for blood CMV DNA, CMV pp65 antigenemia test and histology/immunohistochemistry are recommended diagnostic tools. Valganciclovir or intravenous ganciclovir are recommended as first-line treatment for at least 2 weeks. CONCLUSIONS: CMV infection occurs frequently in immunocompetent subjects with critical illness. CMV pneumonia should especially be considered in patients with severe pneumonia, receiving mechanical ventilation and steroids. Early diagnosis and treatment may help improve the prognosis of these patients. Reference #1: Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med,2009,37:2350-2358 Reference #2: Jain M, Duggal S, Chugh TD. Cytomegalovirus infection in nonimmunosuppressed critically ill patients. J Infect Dev Ctries,2011,5:571-579. Reference #3: Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus Reactivation in Critically-Ill Immunocompetent Patients. JAMA,2008,300:413-422. DISCLOSURE: The following authors have nothing to disclose: Chenjuan Gu, Hong Chen, Yongjie Ding, Guo Chao Shi No Product/Research Disclosure Information

Cytomegalovirus Pneumonia in Patients with Severe COVID-19

Clinical Features of Microbial Reactivation in Early Onset of Severe Pneumonia by Metagenomic Next-Generation Sequencing in Intensive Care Units, a Multicenter, Retrospective Study

Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia

Cytomegalovirus Infection after Severe Pneumonia in Immunocompetent Subjects: A Two-Case Report

Cytomegalovirus, a "Friend" of SARS-CoV-2: A Case Report

Cytomegalovirus Reactivation in Postrenal Transplant Patients Immediately in Association with Coronavirus Disease 2019 (COVID-19) Infection: A Case Report of 2 Patients and a Brief Review of the Literature

Cytomegalovirus and Severe Acute Respiratory Syndrome Coronavirus 2 Co-infection in Renal Transplants: A Retrospective Study from a Single Center

Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization

Hypersensitivity in the Lungs is Responsible for Acute Respiratory Failure in COVID‐19 Patients: Case Series of Patients Who Received High‐dose/short‐term Methylprednisolone

Prevalence and Risk Factors of Pneumomediastinum and Subcutaneous Emphysema in COVID-19 Patients: A Retrospective Cohort Study

Severe Pneumonia and Cytomegalovirus Coinfection in Infants with Human Immunodeficiency Virus Infection

Severe COVID-19 pneumonia in an intensive care setting and comparisons with historic severe viral pneumonia due to other viruses

Cytomegalovirus reactivation in immunocompetent mechanical ventilation patients: a prospective observational study

Viral reactivation in the lungs of patients with severe pneumonia is associated with increased mortality, a multicenter, retrospective study

Immunopathological Changes in SARS-CoV-2 Critical and Non-critical Pneumonia Patients: A Systematic Review to Determine the Cause of Co-infection

Severe covid-19 pneumonia: pathogenesis and clinical management

Late Breaking Abstract - Pulmonary CMV and HSV reactivations in critically ill COVID-19 patients with and without aspergillosis

Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA

Progressive Lung Consolidation in HIV Amidst the COVID-19 Pandemic: Evaluating Probable Cytomegalovirus Pneumonia and the Importance of Early Empirical Treatment

Respiratory follow-up of patients with COVID-19 pneumonia

Risks and Features of Secondary Infections in Severe and Critical Ill COVID-19 Patients